2027 年亚太地区动物保健市场预测 - COVID-19 影响和按产品(处方药和非处方药)进行区域分析;动物类型(生产动物、伴侣动物);和国家

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 143    |    Report Code: TIPRE00013026    |    Category: Life Sciences

Asia Pacific Animal Health Market

市场介绍

通过预防动物疾病流行和监测动物食品供应来控制动物健康对于任何经济和任何国家的安全都至关重要国家的粮食供应。饲养健康的牲畜可以保证食品的安全供应并保持销售价格的稳定。由于牲畜贸易停止、动物屠宰和随后的疾病消除工作,动物疾病流行给该国造成了数百万美元的损失。例如,2017 年 11 月,猪繁殖与呼吸综合征病毒 (PRRSV) 导致仔猪死产,导致美国农民每年损失 6 亿美元。与人类健康相关的动物疾病会对公共卫生、国际贸易和农业部门的稳定产生不利影响。无疾病和健康的动物可能会带来更安全的食品供应、更高的农业生产力、减少环境影响、减少抗生素的使用。

市场概况和动态

亚太动物保健市场预计将从 2018 年的 154.718 亿美元增至 2027 年的 278.84 亿美元。预计 2019-2027 年该市场的复合年增长率为 6.9%。推动市场增长的因素包括蛋白质食品需求增长的举措。然而,动物药物开发和审批流程的高度复杂性和成本可能会对市场增长产生负面影响。

关键细分市场

按产品划分,处方细分市场在2018年亚太动物保健市场中占据最大的市场份额。就动物类型而言,到2027年,生产动物细分市场将在动物保健市场中占据最大的市场份额。

主要来源和列出的公司

动物健康的一些主要一手和二手来源报告中涉及的市场包括疾病控制与预防中心 (CDC)、牛健康与福利组织 (CHAWG)、日本动物医院协会 (JAHA)、兽医公共卫生计划 (VPH) 等。

购买报告的理由

  • 了解动物保健市场格局并确定最有可能保证丰厚回报的细分市场
  • 通过了解不断变化的竞争格局来保持领先地位动物保健市场
  • 通过识别最有可能销售前景的细分市场,有效规划动物保健市场的并购和合作交易
  • 通过对动物保健市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • 获得2018年以来各个细分市场的市场收入预测亚太地区 -2027 年。

 

亚太动物健康市场细分

按产品

  • 处方
    • 饲料添加剂
    • 医药
    • 疫苗
    • 诊断
  • 非处方药
    • 营养品/补充剂
    • 美容产品
    • 杀寄生虫剂

按动物类型

strong>

  • 生产动物
  • 伴侣动物

 

按地理位置划分

 

按地理位置划分

•          亚太地区

  • 中国
  • 日本
  • 印度
  • 澳大利亚
  • 韩国

 

公司简介

  • Virbac
  • Elanco
  • 默克公司有限公司
  • 勃林格殷格翰国际有限公司
  • Ceva Santé; Co., Inc.动物


Asia Pacific Animal Health Strategic Insights

Strategic insights for Asia Pacific Animal Health involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-animal-health-market-strategic-framework.webp
Get more information on this report

Asia Pacific Animal Health Report Scope

Report Attribute Details
Market size in 2018 US$ 15,471.8 Million
Market Size by 2027 US$ 27,884.0 Million
Global CAGR (2019 - 2027) 6.9%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By 产品
  • 处方药
  • 非处方药
By 动物类型
  • 生产动物
  • 伴侣动物
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Virbac
  • Elanco
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Get more information on this report

    Asia Pacific Animal Health Regional Insights

    The regional scope of Asia Pacific Animal Health refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-animal-health-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Animal Health Market

    1. Virbac
    2. Elanco
    3. Merck & Co., Inc.
    4. Boehringer Ingelheim International GmbH
    5. Ceva Santé Animale
    Frequently Asked Questions
    How big is the Asia Pacific Animal Health Market?

    The Asia Pacific Animal Health Market is valued at US$ 15,471.8 Million in 2018, it is projected to reach US$ 27,884.0 Million by 2027.

    What is the CAGR for Asia Pacific Animal Health Market by (2019 - 2027)?

    As per our report Asia Pacific Animal Health Market, the market size is valued at US$ 15,471.8 Million in 2018, projecting it to reach US$ 27,884.0 Million by 2027. This translates to a CAGR of approximately 6.9% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Animal Health Market report typically cover these key segments-

  • 产品 (处方药, 非处方药)
  • 动物类型 (生产动物, 伴侣动物)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Animal Health Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Animal Health Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in Asia Pacific Animal Health Market?

    The Asia Pacific Animal Health Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Virbac
  • Elanco
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Who should buy this report?

    The Asia Pacific Animal Health Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Animal Health Market value chain can benefit from the information contained in a comprehensive market report.